Marker Therapeutics, Inc. Announces 2024 Annual Meeting of Stockholders

TL;DR

Marker Therapeutics will hold its virtual Annual Meeting of Stockholders on June 6, 2024, to elect directors, vote on executive compensation, and ratify auditor selection.

AI Summary

Marker Therapeutics, Inc. (MRKR) filed a Proxy Statement (DEF 14A) with the SEC on April 26, 2024. Annual Meeting of Stockholders to be held virtually on June 6, 2024. Stockholders must register by 11:59 p.m. ET on June 5, 2024. Meeting agenda includes election of five director nominees. Advisory vote on compensation of named executive officers. Ratification of Marcum LLP as independent auditor for fiscal year ending December 31, 2024.

Why It Matters

For investors and stakeholders tracking Marker Therapeutics, Inc., this filing contains several important signals. The election of directors and advisory vote on executive compensation are standard governance procedures that allow shareholders to voice their opinions on company leadership and pay practices. Ratifying Marcum LLP as the independent auditor is crucial for financial transparency and investor confidence, ensuring the accuracy of the company's financial reporting.

Risk Assessment

Risk Level: — Marker Therapeutics, Inc. shows moderate risk based on this filing. The filing is a routine proxy statement with no immediate financial or operational news, indicating a low-risk informational update.

Analyst Insight

Stockholders should review the proxy materials to make informed decisions on director elections and executive compensation at the upcoming annual meeting.

Key Numbers

• 5 — Director Nominees (Number of nominees for the Board of Directors.)
• 2024 — Fiscal Year End (Fiscal year for which Marcum LLP is proposed as auditor.)

Key Players & Entities

• Marker Therapeutics, Inc. (company) — Registrant and filer of the proxy statement.
• Marcum LLP (company) — Proposed independent registered public accounting firm.
• June 6, 2024 (date) — Date of the Annual Meeting of Stockholders.
• April 10, 2024 (date) — Record date for the Annual Meeting.
• June 5, 2024 (date) — Registration deadline for the virtual meeting.

FAQ

Risk Factors

• Compliance with SEC Regulations [low — regulatory]: The company must adhere to SEC rules and regulations for filing proxy statements and conducting shareholder meetings.
• Virtual Meeting Logistics [low — operational]: Ensuring a smooth and accessible virtual meeting experience for all stockholders is critical for participation and voting.
• Auditor Independence and Effectiveness [low — financial]: The selection and ratification of the independent auditor are vital for maintaining the integrity of financial reporting.

Key Dates

• 2024-06-06: Annual Meeting of Stockholders — To elect directors, vote on executive compensation, and ratify auditor selection.
• 2024-04-10: Record Date — Determines which stockholders are eligible to vote at the meeting.
• 2024-06-05: Virtual Meeting Registration Deadline — Last day for stockholders to register for the virtual meeting.

Glossary

Proxy Statement

A document filed with the SEC that provides shareholders with information about matters to be voted on at a shareholder meeting. (Provides essential details for shareholders to make informed voting decisions on director elections and executive compensation.)

Named Executive Officers (NEOs)

The top executive officers of a company whose compensation is disclosed in proxy statements. (Shareholders have an advisory vote on their compensation, allowing them to express their views on executive pay.)

Independent Registered Public Accounting Firm

An external audit firm hired to examine a company's financial statements and provide an opinion on their fairness and accuracy. (Ratification of the auditor is a key governance item ensuring financial reporting integrity.)

Filing Documents

• tm242848-1_def14a.htm (DEF 14A) — 624KB
• lg_markertherapeutics-4clr.jpg (GRAPHIC) — 31KB
• bc_comptsr-4clr.jpg (GRAPHIC) — 77KB
• bc_netincome-4clr.jpg (GRAPHIC) — 67KB
• px_24markerproxy1pg01-4c.jpg (GRAPHIC) — 282KB
• px_24markerproxy1pg02-4c.jpg (GRAPHIC) — 328KB
• 0001104659-24-052914.txt ( ) — 1647KB

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 19 DELINQUENT SECTION 16(A) REPORTS 21

EXECUTIVE COMPENSATION AND KEY EMPLOYEES

EXECUTIVE COMPENSATION AND KEY EMPLOYEES 22 DIRECTOR COMPENSATION 35 TRANSACTIONS WITH RELATED PERSONS AND INDEMNIFICATION 37 HOUSEHOLDING OF PROXY MATERIALS 40 OTHER MATTERS 41 i TABLE OF CONTENTS MARKER THERAPEUTICS, INC. 9350 Kirby Drive, Suite 300 Houston, TX 77054 PROXY STATEMENT FOR THE 2024 ANNUAL MEETING OF STOCKHOLDERS JUNE 6, 2024 QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING Why am I receiving these materials? We have sent you these proxy materials because the Board of Directors (the "Board" or "Board of Directors") of Marker Therapeutics, Inc. (sometimes referred to as the "Company" or "Marker") is soliciting your proxy to vote at the 2024 Annual Meeting of Stockholders, including at any adjournments or postponements of the meeting. You are invited to attend the annual meeting to vote on the proposals described in this proxy statement. However, you do not need to attend the meeting to vote your shares. Instead, you may simply complete, sign and return the enclosed proxy card, or follow the instructions below to submit your proxy over the telephone or through the internet. We intend to mail these proxy materials on or about April 26, 2024 to all stockholders of record entitled to vote at the Annual Meeting. How do I attend the Annual Meeting? The Annual Meeting will be a virtual stockholder meeting through which you can listen to the meeting, submit questions and vote online. In order to attend the Annual Meeting, you must first register at http://viewproxy.com/markertherapeutics/2024/htype.asp by 11:59 p.m. Eastern Time on Wednesday, June 5, 2024. Please follow the instructions on the registration page. You will then receive a meeting invitation by email with your unique link to join the Annual Meeting along with a password prior to the meeting date. We recommend that you log on a few minutes before the Annual Meeting to ensure that you are logged in when the meeting begins. Information on how

View Full Filing

View this DEF 14A filing on SEC EDGAR